Related Experiment Video
Updated: May 18, 2026
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Left atrial appendage occlusion for stroke prevention
Insights
Atrial fibrillation (AF) increases stroke risk via left atrial appendage (LAA) thrombi. LAA occlusion offers an alternative to anticoagulation for stroke prevention in AF patients.
Area of Science:
- Cardiology
- Medical Devices
- Stroke Prevention
Background:
- Atrial fibrillation (AF) is a common arrhythmia linked to thromboembolic stroke.
- The left atrial appendage (LAA) is a primary site for thrombus formation in AF patients.
- Current anticoagulation therapies (warfarin, newer agents) have limitations, including bleeding risks.
Purpose of the Study:
- To review the anatomy and physiology of the LAA.
- To discuss stroke prevention strategies in AF.
- To evaluate LAA occlusion devices and technologies.
Main Methods:
- Literature review of LAA anatomy, physiology, and stroke pathophysiology.
- Analysis of current medical therapies for stroke prevention in AF.
- Review of available LAA occlusion devices and clinical data.
Main Results:
- The LAA is a key source of emboli in AF-related strokes.
- LAA occlusion is an emerging alternative to anticoagulation.
- Various devices and techniques for LAA occlusion are available and under investigation.
Conclusions:
- LAA occlusion presents a promising alternative to long-term anticoagulation for stroke prevention in AF.
- Further data on LAA occlusion technologies are needed to establish their role in clinical practice.
Abstract:
Atrial fibrillation (AF) remains the most common arrhythmia encountered in clinical practice. One of its most devastating complication is the development of thromboembolism leading to stroke. The left atrial appendage (LAA) has been shown to be the site of thrombus formation in the majority of strokes associated with AF. Anticoagulation with warfarin has been the treatment of choice for prevention of embolic events in these patients, but it does have significant limitations including bleeding, need for continued follow-up blood tests, and drug-drug interactions. Although newer anticoagulants have been developed, they still have the potential side effect of causing significant bleeding. Closure or exclusion of the LAA has emerged as an alternative therapeutic approach to medical therapy. The aim of this article is to review the anatomy and physiology of the LAA, discuss the various treatment strategies for stroke prevention, review the current devices and technologies available for LAA occlusion, and discuss some of the more recent data available on these technologies.
